Geum.ru

Стратегия и тактика лечения больных

Вид материалаДокументы

Содержание


Стратегия и тактика лечения больных с узловой патологией щитовидной железы. Часть I : основные типы новообразований //
Институт эндокринологии и обмена веществ им. В. П. Комиссаренко АМН Украины, 04114, г. Киев
Подобный материал:
1   2   3   4   5   6   7   8   9   ...   17

Литература




  1. Эпштейн Е. В., Матящук С. И. Стратегия и тактика лечения больных с узловой патологией щитовидной железы. Часть I : основные типы новообразований // Ліки України. – 2004, № 10.
  2. Parkin D. M., Muir C. S., Whelan S. L. et al. Cancer incidence in five continents // IARC Scientific Publication. – 1992. - Vol. 6.
  3. Franceschi S., Boyle P., Maison-Neuve P. et al. The epidemiology of thyroid carcinoma // Critical Reviews in Oncogenesis. – 1993. - № 4. – Р. 25-52.
  4. Wu H. S., Young M. T., Ituarte P. H. et al. Death from thyroid cancer of follicular cell origin // J. Am. Coll. Surg. – 2000. – 191, № 6. – P. 600-606.
  5. Beasley N. J., Walfish P. G., Witterick I. et al. Cause of death in patients with well-differentiated thyroid carcinoma // Laryngoscope. – 2001. – 111, № 6. – P. 989-991.
  6. Moley J. F. Medullary thyroid carcinoma // Curr. Treat. Options Oncol. – 2003. – 4, № 4. – P. 339-347.
  7. Shimizu K. Oncogenic emergency and treatment in thyroid disease // Nippon Geka Gakkai Zasshi. – 2004. – 105, № 4. – P. 266-270.
  8. Sakamoto A., Kasai N., Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas // Cancer. – 1983. – 15, № 10. – P. 1849-1855.
  9. Шлюмберже М., Пачини Ф. Опухоли щитовидной железы. Paris, «Nucleon». – 1999. – 345 c.
  10. Pellegriti G., Giuffrida D., Scollo C. et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis // Cancer. – 2002. – 95, № 10. – P. 2076-2085.
  11. McIver B., Hay I. D., Giuffrida D. F. et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution // Surgery. – 2001. – 130, № 6. – P. 1028-1034.
  12. Amodeo C., Caglia P., Gandolfo L. et al. Undifferentiated carcinoma of the thyroid // Tumori. – 2003. – 89, № 4. – P. 205-206.
  13. Buzzoni R., Catena L., Cortinovis D. et al. Integrated therapeutic strategies for anaplastic thyroid carcinoma // Tumori. – 2003. – 89, № 5. – P. 544-546.
  14. Богданова Т. И., Козырицкий В. Г., Тронько Н. Д. Патология щитовидной железы у детей (атлас). К. : Чернобыльинтеринформ. - 2000. - 158 с.
  15. Mazzaferri E. L., Jhiang S. M. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer // Am. J. Med. – 1994, 97. – P. 418-428.
  16. Gyory F., Lukacs G., Nagy E. V. et al. Differentiated thyroid carcinoma: prognostic factors // Magy Seb. – 2001. – 54, № 2. – P. 69-74.
  17. Tachikawa T., Kumazawa H., Kyomoto R. et al. Clinical study on prognostic factors in thyroid carcinoma // Nippon Jibiinkoka Gakkai Kaiho. – 2001. – 104, № 2. – P. 157-164.
  18. Pelizzo M. R., Toniato A., Grigoletto R. et al. Papillary carcinoma of the thyroid. A uni- and multivariate analysis of the factors affecting the prognosis inclusive of surgical treatment // Minerva Chir. – 1998. – 53, № 6. – P. 471-482.
  19. Marchesi M., Biffoni M., Biancari F. et al. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma // Eur. J. Surg. Suppl. – 2003. – 588. – P. 46-50.
  20. Schroder S., Bocker W., Dralle H. et al. The encapsulated papillary carcinoma of the thyroid: a morphologic subtype of the papillary thyroid carcinoma // Cancer. – 1984. – 54. – P. 90-93.
  21. Эпштейн Е. В., Матящук С. И. Ультразвуковое исследование щитовидной железы. Атлас-руководство. Изд. 2-е. – К.: “КВІЦ”, 2004. - 382 с.
  22. Moreno A., Rodriguez J. M., Sola J. et al. Encapsulated papillary neoplasm of the thyroid: retrospective clinicopathological study with long term follow up // Eur. J. Surg. – 1996. – 162, № 3. – P. 177-180.
  23. Vickery A. L. Thyroid papillary carcinoma. Pathological and philosophical controversies // Am. J. Surg. Pathol. – 1983. – 7, № 8. – P. 797-807.
  24. Hedinger Chr., Williams E. K., Sobin L. H. Histological typing of thyroid tumors.-WHk, 2nd Edn. Berlin: Springer. – 1988. – 66 p.
  25. Lang W., Borrusch H., Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies // Am. J. Clin. Pathol. – 1988. – 90. – P. 72-76.
  26. Hay I. D., Grant C. S., Van Heerden J. A. et al. Papillary thyroid microcarcinoma : a study of 535 cases observed in a 50 year period // Surgery. – 1992. – 112. – P. 1139-1147.
  27. Цыб А. Ф., Паршин В. С., Нестайко Г. В. и др. Ультразвуковая диагностика заболеваний щитовидной железы. – М.: Медицина, 1997. - 332 с.
  28. Lang W., Borrusch H., Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies // Am. J. Clin. Pathol. – 1988. – 90, № 1. – Р. 72-76.
  29. Ito Y., Uruno T., Nakano K. et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid // Thyroid. – 2003. – 13, № 4. – P. 381-387.
  30. Bucci A., Shore-Freedman E., Gierlowski T. et al. Behavior of small thyroid cancers found by screening radiation-exposed individuals // J. Clin. Endocrinol. Metab. – 2001. – 86, № 8. – Р. 3711-3716.
  31. Perez L. A., Gupta P. K., Mandel S. J. et al. Thyroid papillary microcarcinoma. Is it really a pitfall of fine needle aspiration cytology ? // Acta Cytol. – 2001. – 45, № 3 . – Р. 341-346.
  32. Sugino K., Ito K Jr., Ozaki O. et al. Papillary microcarcinoma of the thyroid // J. Endocrinol. Invest. – 1998. – 21, № 7. – Р. 445-448.
  33. Falvo L., D'Ercole C., Sorrenti S. et al. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype // Eur. J. Surg. Suppl. – 2003. – 588. – P. 28-32.
  34. Furlan J. C., Bedard Y., Rosen I. B. Biologic basis for the treatment of microscopic, occult well-differentiated thyroid cancer // Surgery. – 2001. – 130, № 6. – P. 1050-1054.
  35. Melliere D. Small thyroid nodules and microcancers // Presse Med. – 1995. – 24, № 33. – P. 1552-1554.
  36. Noguchi S., Yamashita H., Murakami N. et al. Small carcinomas of the thyroid. A long-term follow-up of 867 patients // Arch. Surg. – 1996. – 131, № 2. – P. 187-191.
  37. Chow S. M., Law S. C., Chan J. K. et al. Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality // Cancer. – 2003. – 98, № 1. – P. 31-40.
  38. Tielens E. T., Sherman S. I., Hruban R. H. et al. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study // Cancer. – 1994. – 73, № 2. P. 424-431.
  39. Jain M., Khan A., Patwardhan N. et al. Follicular variant of papillary thyroid carcinoma : a comparative study of histopathologic features and cytology results in 141 patients // Endocr. Pract. – 2001. – 7, № 2. – P. 79-84.
  40. Evans H. L. Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis // Cancer. – 1984. – 54, № 3. – P. 535-540.
  41. Passler C., Prager G., Scheuba C. et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up // Arch. Surg. – 2003. – 138, № 12. – P. 1362-1366.
  42. Nikiforov Y. E., Erickson L. A., Nikiforova M. N. et al. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior // Am. J. Surg. Pathol. – 2001. – 25, № 12. – P. 1478-1484.
  43. Sywak M., Pasieka J. L., Ogilvie T. A review of thyroid cancer with intermediate differentiation // J. Surg. Oncol. – 2004. – 86, № 1. – P. 44-54.
  44. Williams E. D., Abrosimov A., Bogdanova T. et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness // Br. J. Cancer. – 2004. – 90, № 11. – P. 2219-2224.
  45. Belchetz G., Cheung C. C., Freeman J. et al. Hurthle cell tumors : using molecular techniques to define a novel classification system // Arch. Otolaryngol. Head Neck Surg. – 2002. – 128, № 3. – P. 237-240.
  46. Hamann A., Gratz K. F., Soudah B. et al. The clinical course of oxyphilic carcinoma of the thyroid // Nuklearmedizin. – 1992. – 31, № 6. – P. 230-238.
  47. Baloch Z. W., Mandel S., LiVolsi V. A. Combined tall cell carcinoma and Hurthle cell carcinoma (collision tumor) of the thyroid // Arch. Pathol. Lab. Med. – 2001. – 125, № 4. – P. 541-543.
  48. Shaha A. R., Ferlito A., Rinaldo A. Distant metastases from thyroid and parathyroid cancer // ORL J. Otorhinolaryngol. Relat. Spec. – 2001. – 63, № 4. – Р. 243-249.
  49. Foote R. L., Brown P. D., Garces Y. I. et al. Is there a role for radiation therapy in the management of Hurthle cell carcinoma ? // Int. J. Radiat. Oncol. Biol. Phys. – 2003. - 56, № 4. – P. 1067-1072.
  50. Chow S. M., Chan J. K., Law S. C. et al. Diffuse sclerosing variant of papillary thyroid carcinoma - clinical features and outcome // Eur. J. Surg. Oncol. – 2003. – 29, № 5. – P. 446-449.
  51. Macak J., Michal M. Diffuse sclerosing variant of papillary thyroid carcinoma // Cesk. Patol. – 1993. – 29, № 1. – Р. 6-8.
  52. Carcangiu M. L., Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases // Am. J. Surg. Pathol. – 1989. – 13, № 12. – Р. 1041-1049.
  53. Heffess C. S., Wenig B. M., Thompson L. D. Metastatic renal cell carcinoma to the thyroid gland : a clinicopathologic study of 36 cases // Cancer. – 2002. – 95, № 9. – Р. 1869-1878.
  54. Civantos F., Albores-Saavedra J., Nadji M. et al. Clear cell variant of thyroid carcinoma // Am. J. Surg. Pathol. – 1984. – 8, № 3. Р. 187-192.
  55. Koo H. L., Jang J., Hong S. J. et al. Renal cell carcinoma metastatic to follicular adenoma of the thyroid gland. A case report // Acta Cytol. – 2004. – 48, № 1. – Р. 64-68.
  56. Asanuma K., Sugenoya A., Ohashi T. et al. Pure clear cell papillary thyroid carcinoma with chronic thyroiditis : report of a case // Surg. Today. – 1998. – 28, № 4. – Р. 464-466.
  57. Hefer T., Joachims H. Z., Eitan A. et al. Are the morphology of papillary thyroid carcinoma and the tumour's behaviour correlated ? // J. Laryngol. Otol. – 1996. – 110, № 7. – Р. 704-705.
  58. Johnson T. L., Lloyd R. V., Thompson N. W. et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma // Am. J. Surg. Pathol. – 1988. – № 12. – Р. 22-27.
  59. Terry J. H., John S. A., Karrowsky J. F. et al. Tall cell papillary thyroid cancer : incidence and prognosis // Am. J. Surg. – 1994. – 168. – P. 459-461.
  60. Mai K. T., Perkins D. G., Yazdi H. M. et al. Infiltrating papillary thyroid carcinoma: review of 134 cases of papillary carcinoma // Arch. Pathol. Lab. Med. – 1998. – 122, № 2. – Р. 166-171.
  61. Solomon A., Gupta P. K., LiVolsi V. A. et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens // Diagn. Cytopathol. – 2002. – 27, № 3. – Р. 143-148.
  62. Ferrer Garcia J. C., Merino Torres J. F., Ponce Marco J. L. et al. Unusual metastasis of differentiated thyroid carcinoma // An. Med. Interna. – 2002. – 19, № 11. – Р. 579-582.
  63. Franssila K. O., Ackerman L. V., Brown C. L. et al. Follicular carcinoma // Semin. Diagn. Pathol. – 1985. – 2, № 2. – Р. 101-122.
  64. Lang W., Choritz H., Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings // Am. J. Surg. Pathol. – 1986. – 10. – P. 246-255.
  65. Brennan M. D., Bergstrahl E. J., Van Heerden J. A. et al. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970 : initial manifestations, pathologic findings, therapy and outcome // Mayo Clin. Proc. – 1991. – 66. – P. 11-22.
  66. Wong N. A., Willott J., Kendall M. J. et al. Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumours: comparison of different methods of assessing vascularity // J. Clin. Pathol. – 1999. – 52, № 8. – Р. 593-597.
  67. Thompson L. D., Wieneke J. A., Paal E. et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature // Cancer. – 2001. – 91, № 3. – Р. 505-524.
  68. Yamashina M. Follicular neoplasms of the thyroid. Total circumferential evaluation of the fibrous capsule // Am. J. Surg. Pathol. – 1992. – 16, № 4. – Р. 392-400.
  69. D'Avanzo A., Treseler P., Ituarte P. H. et al. Follicular thyroid carcinoma: histology and prognosis // Cancer. – 2004. – 100, № 6. – Р. 1123-1129.
  70. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland // Arch. Otolaryngol. Head Neck Surg. – 2003. – 129, № 2. – Р. 207-210.
  71. Stojadinovic A., Ghossein R. A., Hoos A. et al. Hurthle cell carcinoma: a critical histopathologic appraisal // J. Clin. Oncol. – 2001. – 19, № 10. – Р. 2616-2625.
  72. Lairmore T. C., Wells S. A. Medullary carcinoma of the thyroid : current diagnosis and management // Seminars in Surgical Oncology. – 1991. – 7. – P. 92-99.
  73. Ellenhorn J. D., Shah J. P., Brennan M. F. Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland // Surgery. – 1993. – 114. – P. 1078-1082.
  74. Crosfeld F., Lips C., Ten Kroode H. et al. Psychosocial consequences of DNA analysis for MEN Type 2 // Oncology. – 1996. – 10. – P. 141-157.
  75. Schlumberger M., Gardet P., De Vathaire F. et al. External radiotherapy and chemotherapy in MTC patients // In : Medullary Thyroid Carcinoma, Calmettes C., Guliana J., Eds. Colloque INSERM/John Libbey. Eurotext Ltd 1991, 211: 213-220.
  76. Samaan N. A., Draznin M. B., Halpin R. E. et al. Multiple endocrine syndrome type IIb in early childhood // Cancer. – 1991. – 68. – P. 1832-1834.
  77. Parmentier C., Gardet P., De Vathaire F. et al. Prognostic factors in medullary thyroid carcinoma (MTC) : a study based on 207 patients treated at the Institute Gustave-Roussy // In : Medullary Thyroid Carcinoma, Calmettes C., Guliana J., Eds. Colloque INSERM/John Libbey. Eurotext Ltd 1991, 211: 193-198.
  78. Pellegriti G., Leboulleux S., Baudin E. et al. Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging // Br. J. Cancer. – 2003. – 88, № 10. – Р. 1537-1542.
  79. Raue F., Winter J., Frank-Raue K. et al. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma // Horm. Metab. Res. Suppl. – 1989. – 21. – Р. 31-34.
  80. Raikhlin N. T., Smirnova E. A., Satylganov I. Histological variants of thyroid medullary carcinoma // Arkh. Patol. – 2001. – 63, № 3. – Р. 10-14.
  81. Hamy A., Raffaitin P., Floch I. et al. The importance of lymph node dissection in medullary thyroid macrocarcinomas // Ann. Chir. – 2003. – 128, № 7. – Р. 447-451.
  82. Hassoun A. A., Hay I. D., Goellner J. R. et al. Insular thyroid carcinoma in adolescents: a potentially lethal endocrine malignancy // Cancer. – 1997. – 79, № 5. – Р. 1044-1048.
  83. Yusuf K., Reyes-Mugica M., Carpenter T. O. Insular carcinoma of the thyroid in an adolescent : a case report and review of the literature // Curr. Opin. Pediatr. – 2003. – 15, № 5. – Р. 512-515.
  84. Pietribiasi F., Sapino A., Papotti M. et al. Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy // Am. J. Clin. Pathol. – 1990. – 94, № 6. – Р. 687-692.
  85. Decaussin M., Bernard M.H., Adeleine P. et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component // Am. J. Surg. Pathol. – 2002. – 26, № 8. – Р. 1007-1015.
  86. Cornetta A. J., Burchard A. E., Pribitkin E. A. et al. Insular carcinoma of the thyroid // Ear Nose Throat J. – 2003. – 82, № 5. – Р. 384-386, 388-389.
  87. Mizukami Y., Nonomura A., Michigishi T. et al. Poorly differentiated ('insular') carcinoma of the thyroid // Pathol. Int. – 1995. – 45, № 9. – Р. 663-668.
  88. Volante M., Landolfi S., Chiusa L. et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients // Cancer. – 2004. – 100, № 5. – Р. 950-957.
  89. Bombardieri E., Seregni E., Villano C. et al. Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer // Tumori. – 2003. – 89, № 5. – Р. 533-536.
  90. Falvo L., Catania A., D'Andrea V. et al. Prognostic factors of insular versus papillary/follicular thyroid carcinoma // Am. Surg. – 2004. – 70, № 5. – Р. 461-466.
  91. Wiseman S. M., Loree T. R., Rigual N. R. Anaplastic transformation of thyroid cancer : review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy // Head Neck.- 2003. – 25, № 8. – Р. 662-670.
  92. Hunt J. L., Tometsko M., LiVolsi V. A. et al. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid // Am. J. Surg. Pathol. – 2003. – 27, № 12. – Р. 1559-1564.
  93. Urciuoli P., Ghinassi S., Iavarone C. et al. Thyroid anaplastic tumor: our experience // Chir. Ital. – 2003. – 55, № 6. – Р. 835-840.
  94. Schindler A. M., Van Melle G., Evequoz B. et al. Prognostic factors in papillary carcinoma of the thyroid // Cancer. – 1991. – 68. – P. 324-330.
  95. Shah J. P., Loree T. R., Dharker D. et al. Prognostic factors in differentiated carcinoma of the thyroid gland // Am. J. Med. – 1992. – 164. – P. 658-661.
  96. Sophocleous S., Ehrenheim C., Fischer J. et al. Low-risk thyroid carcinoma - therapy, follow-up and prognosis // Nuklearmedizin. – 1997. – 36, № 3. – Р. 93-102.
  97. Witt R. L., McNamara A. M. Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer // Ear Nose Throat J. – 2002. – 81, № 12. – Р. 856-863.
  98. Pellegriti G., Scollo C., Lumera G. et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases // J. Clin. Endocrinol. Metab. – 2004. – 89, № 8. – Р. 3713-3720.
  99. Katoh R., Sasaki J., Kurihara H. et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma : a clinico-pathologic study of 105 consecutive patients // Cancer. – 1992. – 70. – P. 1585-1590.
  100. De Groot L. J., Kaplan E. L., Mc Cormick M. et al. Natural history, treatment and course of papillary thyroid carcinoma // J. Clin. Endocrinol. Metab. – 1990. – 71. – P. 414-424.
  101. Beasley N. J., Lee J., Eski S. et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer // Arch. Otolaryngol. Head Neck Surg. – 2002. – 128, № 7. – Р. 825-828.
  102. Pacini F., Elisei R., Capezzone M. et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients // Thyroid. – 2001. – 11, № 9. – Р. 877-881.
  103. Matsuzuka T., Matsuura H., Hasegaga Y. et al. Distribution of intraglandular metastatic foci in the contralateral lobe of papillary thyroid carcinoma // Nippon Jibiinkoka Gakkai Kaiho. – 2000. – 103, № 10. – Р. 1150-1154.
  104. Furlan J. C., Bedard Y. C., Rosen I. B. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas // J. Am. Coll. Surg. – 2004. – 198, №3. – Р. 341-348.
  105. Gemsenjager E., Heitz P. U., Seifert B. et al. Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years // Swiss Med. Wkly. – 2001. – 131, № 11-12. – Р. 157-163.
  106. van Tol K. M., de Vries E. G., Dullaart R. P. et al. Differentiated thyroid carcinoma in the elderly // Crit. Rev. Oncol. Hematol. – 2001. – 38, № 1. – Р. 79-91.
  107. Palme C. E., Waseem Z., Raza S. N. et al. Management and outcome of recurrent well-differentiated thyroid carcinoma // Arch. Otolaryngol. Head Neck Surg. – 2004. – 130, № 7. – Р. 819-824.
  108. Salvesen H., Njolstad P. R., Akslen L. A. et al. Papillary thyroid carcinoma : a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system // Eur. J. Surg. – 1992. – 158. – P. 583.
  109. Ortiz S., Rodriguez J. M., Soria T. et al. Extrathyroid spread in papillary carcinoma of the thyroid : Clinicopathological and prognostic study // Otolaryngol. Head Neck Surg. – 2001. – 124, № 3. – Р. 261-265.
  110. Asanuma K., Kusama R., Maruyama M. et al. Macroscopic extranodal invasion is a risk factor for tumor recurrence in papillary thyroid cancer // Cancer Lett. – 2001. – 164, № 1. – Р. 85-89.
  111. Sugitani I., Kasai N., Fujimoto Y. et al. A novel classification system for patients with PTC : addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period // Surgery. – 2004. – 135, № 2. – Р. 139-148.
  112. Akslen L. A., Myking A. O. Differentiated thyroid carcinomas : the relevance of various pathological features for tumor classification and prediction of tumor progress // Virchows Arch. (A). – 1992. – 421. – Р. 17-23.
  113. Grebe S., Hay I. D. Thyroid cancer nodal metastases : biologic significance and therapeutic considerations // Surg. Oncol. Clin. N. Amer. – 1996. – 5. – Р. 43-63.
  114. De Jong S. A., Demeter J. G., Jarosz H. et al. Primary papillary thyroid carcinoma presenting as cervical lymphadenopathy : the operative approach to the "lateral aberrant thyroid" // Am. Surg. – 1993. – 59, № 3. – Р. 172-176.
  115. Machens A., Holzhausen H. J., Lautenschlager C. et al. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma // Cancer. – 2003. – 98, № 4. – Р. 712-719.
  116. Hall F. T., Freeman J. L., Asa S. L. et al. Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma // Arch. Otolaryngol. Head Neck Surg. – 2003. – 129, № 7. – Р. 716-719.
  117. Касаткина Э. П., Шилин Д. Е., Пыков М. И. Ультразвуковое исследование щитовидной железы у детей и подростков. - М.: Видар, 1999. - 56 с.
  118. Bruneton J. N. Ultrasonography of the neck. – Heidelberg: Sprinter-Verlag, 1987. - 118 p.
  119. Giuffrida D., Santonocito M. G., Iurato M. P. et al. Echography at "high resolution" in the diagnosis of cervical lymphadenopathies in follow-up of thyroid carcinoma // Minerva Endocrinol. – 1997. – 22, № 3. – Р. 61-66.
  120. Coburn M., Wanebo H. J. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer // Am. J. Surg. – 1992. – 164. – Р. 671-676.
  121. Gyory F., Balazs G., Nagy E. V. et al. Differentiated thyroid cancer and outcome in iodine deficiency // Eur. J. Surg. Oncol. – 2004. – 30, № 3. – Р. 325-331.
  122. Wu Y., Wang J. D., Yuan J. D. et al. Papillary microcancer of the thyroid // Ann. Chir. – 1995. – 49, № 10. – Р. 959-962.
  123. Kitajiri S., Hiraumi H., Hirose T. et al. The presence of large lymph node metastasis as a prognostic factor of papillary thyroid carcinoma // Auris Nasus Larynx. – 2003. – 30, № 2. – Р. 169-174.
  124. Coburn M., Teates D., Wanebo H. J. Recurrent thyroid cancer : role of surgery versus radioactive iodine (I131) // Ann. Surg. – 1994. – 219. – P. 587-595.
  125. Shoup M., Stojadinovic A., Nissan A. et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma // J. Am. Col.l Surg. – 2003. – 197, № 2. – Р. 191-197.
  126. Pacini F., Cetani F., Miccoli P. et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine // World J. Surg. – 1994. – 18. – P. 600-604.
  127. Schlumberger M., Challeton C., De Vathaire F. et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma // J. Nucl. Med. – 1996. – 37. – P. 598-605.
  128. Casara D., Rubello D., Saladini G. et al. Different features of pulmonary metastases in differentiated thyroid cancer : natural history and multivariate analysis of prognostic variables // J. Nucl. Med. – 1993. – 34. – P. 1626-1631.
  129. Proye C., Dromer D., Carnaille B. et al. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine ? // World J. Surg. – 1992. – 16. – P. 640-646.
  130. Dinneen S., Valimaki M., Bergstralh E. et al. Distant metastases in papillary thyroid carcinoma : 100 cases observed at one institution during 5 decades // J. Clin. Endocrinol. Metab. – 1995. – 80. – P. 2041-2045.
  131. Akslen L., Haldorsen T., Thoresen S. et al. Survival and causes of death in thyroid cancer : a population-based study of 2479 cases from Norway // Cancer Res. – 1991. – 51. – P. 1234-1241.
  132. Kim S., Wei J. P., Braveman J. M. et al. Predicting outcome and directing therapy for papillary thyroid carcinoma // Arch. Surg. – 2004. – 139, № 4. – Р. 390-394.
  133. Furmanchuk A., Averkin J., Egloff B. et al. Pathomorphological findings in thyroid cancer of children from the Republic of Belarus. A study of 86 cases occurring between 1986 (post-Chernobyl) and 1991 // Histopathology. – 1992. – 21. – P. 401-408.
  134. Cady B. Papillary carcinoma of the thyroid // Semin. Surg. Oncol. – 1991. – 7, № 2. – Р. 81-86.
  135. Grigsby P. W., Gal-or A., Michalski J. M. et al. Childhood and adolescent thyroid carcinoma // Cancer. – 2002. – 95, № 4. – Р. 724-729.
  136. Vini L., Hyer S., Marshall J. et al. Long-term results in elderly patients with differentiated thyroid carcinoma // Cancer. – 2003. – 97, № 11. – Р. 2736-2742.
  137. Lundgren C., Hall P., Ekbom A. et al. Incidence and survival of Swedish patients with differentiated thyroid cancer // Int. J. Cancer. – 2003. – 106, № 4. – Р. 569-573.
  138. Vosberg H. Diagnosis, radioiodine and radiotherapy of thyroid carcinomas // Schweiz. Rundsch. Med. Prax. – 1998. – 87, № 11. – Р. 376-382.
  139. Vassilopoulou-Sellin R. Management of papillary thyroid cancer // Oncology (Huntingt). – 1995. - № 2. – Р. 145-151.
  140. Cohen J., Kalinyak J., McDougall I. Modern management of differentiated thyroid cancer // Cancer Biother. Radiopharm. – 2003. – 18, № 5. – Р. 689-705.
  141. Lind P., Gallowitsch H., Mikosch P. et al. Comparison of different tracers in the follow up of differentiated thyroid arcinoma // Acta Med. Austriaca. – 1999. – 26, № 4. – Р. 115-117.
  142. Hay I., Bergstralh E., Goellner J. et al. Predicting outcome in papillary thyroid carcinoma : development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 // Surgery. – 1993. – 114. – P. 1050-1058.
  143. Rubino C., de Vathaire F., Dottorini M. et al. Second primary malignancies in thyroid cancer patients // Br. J. Cancer. – 2003. – 89, № 9. – Р. 1638-1644.
  144. Lamonica D. Iodine 131 (131)I as adjuvant therapy of differentiated thyroid cancer // Surg. Oncol. Clin. N. Am. – 2004. – 13, № 1. – Р. 129-149.
  145. Dulgeroff A., Hershman J. Medical therapy for differentiated thyroid carcinoma // Endocr. Rev. – 1994. – 15. – P. 500-515.
  146. Zidan J., Hefer E., Iosilevski G. et al. Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer // Int. J. Radiat. Oncol. Biol. Phys. – 2004. – 59, № 5. – Р. 1330-1336.
  147. Sawka A., Thephamongkhol K., Brouwers M. et al. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer // J. Clin. Endocrinol. Metab. – 2004. – 89, № 8. – Р. 3668-3676.
  148. De Vathaire F., Schlumberger M., Delisle et al. Leukemias and cancers following I-131 administration for thyroid cancer // Br. Cancer. – 1997. – 75. – P. 734-739.
  149. Dottorini M., Lomuscio G., Mazzucchelli L. et al. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma // J. Nucl. Med. – 1995. – 36. – P. 21-27.
  150. Chow S., Law S., Mendenhall W. et al. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine // Pediatr. Blood Cancer. – 2004. – 42, №2. – Р. 176-183.
  151. Coronado Poggio M., Martin Curto L., Marin F. et al. Follow-up of children and young adults with differentiated thyroid cancer treated with radioiodine // Rev. Esp. Med .Nucl. – 2003. – 22, № 5. – Р. 316-326.
  152. Besic N., Vidergar-Kralj B., Frkovic-Grazio S. et al. The role of radioactive iodine in the treatment of Hurthle cell carcinoma of the thyroid // Thyroid. – 2003. – 13, № 6. – Р. 577-584.
  153. van Tol K., Jager P., de Vries E. et al. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin // Eur. J. Endocrinol. – 2003. – 148, № 6. – Р. 589-596.
  154. Koh J., Kim E., Ryu J. et al. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan : comparative study // Clin. Endocrinol. (Oxf). – 2003. – 58, № 4. – Р. 421-427.
  155. McConahey W. M., Hay I. D., Woolner L. B. al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970 : initial manifestations, pathologic findings, therapy and outcome // Mayo Clin. Proc – 1986. – 61. – Р. 978-996.
  156. Romano G., Luna E., Cocchiara G. et al. The surgical treatment of nodular thyroid lesions: our experience. Analysis of 462 cases // G. Chir. – 2004. – 25, № 1-2. – Р. 23-26.
  157. Busnardo B., Girelli M. E., Rubello D. et al. Favorable long term results in patients with small differentiated thyroid cancer not treated with radioiodine // Tumori. – 1989. – 75. – P. 57-59.
  158. Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma // Surgery. – 1988. – 104. – P. 947-953.
  159. Guercioni G., Siquini W., Taccaliti A. et al. Surgical treatment of differentiated thyroid carcinoma // Ann. Ital. Chir. – 2003. – 74, № 5. – Р. 501-509.
  160. Baldet L., Manderscheid J. C., Glinoer D. et al. The management of differentiated thyroid cancer in Europe in 1988. Results of an international survey // Acta Endocrinol. (Copenh). – 1989. – 120, № 5. – Р. 547-558.
  161. Visa Zueras M. T., Alonso Blanco M., Yturriaga Matarranz R. et al. Differentiated thyroid carcinoma in childhood // An. Esp. Pediatr. – 1992. – 37, № 1. – Р. 11-14.
  162. Simon D., Goretzki P. E., Witte J. et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma // World J. Surg. – 1996. – 20, № 7. – Р. 860-866.
  163. Kouvaraki M. A., Shapiro S. E., Fornage B. D. et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer // Surgery. – 2003. – 134, № 6. – Р. 946-954.
  164. McGregor L. M., Rosoff P. M. Follicle-derived thyroid cancer in young people: the Duke experience // Pediatr. Hematol. Oncol. – 2001. – 18, № 2. – Р. 89-100.
  165. Hay I. D. Papillary thyroid carcinoma // Endocrinol. Metab. Clin. N. Am. – 1990. – 19. – P. 545-576.
  166. Frasoldati A., Pesenti M., Gallo M. et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma // Cancer. – 2003. – 97, № 1. – Р. 90-96.
  167. Wang T. S., Dubner S., Sznyter L. A. et al. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes // Arch. Otolaryngol. Head Neck Surg. – 2004. – 130, № 1. – Р. 110-113.
  168. Samaan N. A., Schultz P. N., Hickey R. C. et al. The results of various modalities of treatment of well differentiated thyroid carcinoma : a retrospective review of 1599 patients // J. Clin. Endocrinol. Metab. – 1992. – 75. – P. 714-720.
  169. Asanuma K., Kobayashi S., Sugenoya A. et al. Clinical recurrence of papillary thyroid cancer in the remnant lobe // Eur. J. Surg. – 2000. – 166, № 3. – Р. 202-206.
  170. Powers P. A., Dinauer C. A., Tuttle R. M. et al. Treatment of recurrent papillary thyroid carcinoma in children and adolescents // J. Pediatr. Endocrinol. Metab. – 2003. – 16, № 7. – Р. 1033-1040.
  171. Tubiana M., Schlumberger M., Rougier P. et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma // Cancer. – 1985. – 55. – P. 794-804.
  172. Матящук С. И. Диагностические возможности ультразвукового исследования щитовидной железы // Ліки України. – 2004. – Т. 83, № 6. – С. 34-39.
  173. Эпштейн Е. В., Божок Ю. М., Матящук С. И. и др. Дифференциальная диагностика опухолей щитовидной железы : прошлое, настоящее и будущее // Ліки України. – 2004. – Т. 84-85, № 7-8. – С. 46-49.
  174. Dean S. D, Hay I. D. Prognostic indicators in differentiated thyroid carcinoma // Cancer. – 2000. – 7, № 3. – Р. 229-239.
  175. Fleming I. D., Cooper J. S., Henson D. E. et al. AJCC Cancer Staging Manual. 5th ed. // American Joint Committee on Cancer. Philadelphia, Pa: Lippincott-Raven; 1997.



Журн. „Ліки України”, 2005, №№ 4, 7 -10


Е. В. Эпштейн, С. И. Матящук

Институт эндокринологии и обмена веществ им. В. П. Комиссаренко

АМН Украины, 04114, г. Киев